Table 2.

Comparisons of facility types treating EOC in terms of Charlson/Deyo Comorbidity Index (2003–2007), age and adherence to treatment status (1998–2007).

	Facility Type
	Community cancer program		Comprehensive community cancer program		Academic/research program		Total
	N	%	N	%	N	%	N	%
Charlson/Deyo Comorbidity Index
0: no co-morbidities	4209	80.28	16,797	81.11	18,034	83.14	39,040	81.94
1	809	15.43	3074	14.84	2965	13.67	6848	14.37
2	178	3.40	670	3.24	559	2.58	1407	2.95
3	47	0.90	168	0.81	132	0.61	347	0.73
Total	5243	100.00	20,709	100.00	21,690	100.00	47,642	100.00
Age
<60 years	4267	37.66	17,311	40.45	20,671	48.44	42,249	43.64
60–75 years	4187	36.96	16,344	38.19	15,508	36.34	36,039	37.23
>75 years	2875	25.38	9141	21.36	6498	15.23	18,514	19.13
Total	11,329	100.00	42,796	100.00	42,677	100.00	96,802	100.00
Overall adherence to NCCN guidelines of care
Adherent	3491	30.81	17,416	40.70	20,956	49.10	41,863	43.25
Non-adherent	7838	69.19	25,380	59.30	21,721	50.90	54,939	56.75
Total	11,329	100.00	42,796	100.00	42,677	100.00	96,802	100.00
Tumor stage
I	2021	17.84	7585	17.72	7750	18.16	17,356	17.93
II	931	8.22	3562	8.32	3448	8.08	7941	8.20
III	4345	38.35	18,916	44.20	20,657	48.40	43,918	45.37
IV	4032	35.59	12,733	29.75	10,822	25.36	27,587	28.50
Total	11,329	100.00	42,796	100.00	42,677	100.00	96,802	100.00
Tumor grade
Well/moderately differentiated (ref)	2998	38.73	11,072	34.27	11,068	32.81	25,138	34.07
Poorly/undifferentiated/anaplastic	4743	61.27	21,236	65.73	22,662	67.19	48,641	65.93
Total	7741	100.00	32,308	100.00	33,730	100.00	73,779	100.00

Notes:

1. Charlson/Deyo Comorbidity Index:

1. 0: no co-morbidities.
2. 1: MI, CHF, peripheral vascular disease; cerebrovascular disease; dementia; CPD; RD; PUD; mild liver disease.
3. 2: diabetes; diabetes with chronic complications; hemiplegia or paraplegia; renal disease.
4. 3: moderate or severe liver disease.